Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
by Ronald Phelps I had surgery to remove an acoustic neuroma, also known as a vestibular schwannoma. The tumor was benign, and the surgery itself went well. For that, I
by Ayis Andreas Caperonis My name is Ayis, and my life changed when I was thirteen and a half years old. I grew up in a very athletic family. My
by Justin Kim I am a brain tumor survivor. I was diagnosed in 2002 and again in 2004. I have been in remission since 2005. That is the short version
by Madison McConnell My life flipped upside down and backwards on August 9, 2025. I went to the emergency room after a four-week migraine that had grown impossible to ignore.
by Keith Brady Here I am, just over three years down the track, still surviving a glioblastoma. A nasty bugger it is, or was. When I look back, my journey
As we move through 2026, I am energized by the momentum building across the American Brain Tumor Association (ABTA) and the community we serve. Meet Hope Head On is more than a campaign; it
To celebrate mentor–mentee partnerships that help drive the neuro-oncology field forward, the ABTA is proud to feature Nader Sanai, MD, and Charuta Furey, MD, two neurosurgeons dedicated to improving care
The ABTA is proud to announce the funding of a Special Project grant focused on treating and monitoring patients with leptomeningeal disease (LMD). Supported by the Flexible Research Fund, this
Sponsored Content On December 2, 2025, Imvax, Inc. announced top-line results from a Phase 2b clinical trial of IGV-001, an investigational autologous biologic-device combination product, in 99 adults with newly
Always free for patients & caregivers
